253 results
Page 4 of 13
8-K
EX-10.1
k2zyl dte7gc9c
10 Feb 14
Proceeds support BDSI’s complete execution of anticipated 2014 commercial launch plans for BUNAVAIL™ and funding of Clonidine Topical Gel NDA program
12:00am
8-K
EX-10.1
ero4ji69dt7
23 Oct 13
BioDelivery Sciences Appoints Ernest De Paolantonio
12:00am
8-K
EX-10.1
5iz1ombch
11 Jul 13
BioDelivery Sciences Adds $20 Million with Debt Financing
12:00am
8-K
EX-10.1
m7oge2 8j7w4hufd2
1 Apr 13
BioDelivery Sciences Expands Product Pipeline with Acquisition of
12:00am
8-K
EX-10.1
qaxg uwog
28 Nov 12
BioDelivery Sciences Announces $40 Million Registered Financing
12:00am
8-K
EX-10.1
lt5fmvr13fw gqmnuq
19 Sep 12
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
cy72yozad7hwghnaa4
11 Jan 12
BioDelivery Sciences Announces Worldwide License and Development Agreement with Endo Pharmaceuticals for BEMA Buprenorphine
12:00am
8-K
EX-10.1
w9szuhobh r9rv8
13 May 11
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
c7azrl4wnf9w
16 Mar 11
BioDelivery Sciences Announces Business Update Call Following Pricing of
12:00am
8-K
EX-10.1
obw u211f
8 Oct 10
Commercial Partnership for BEMA Fentanyl in Taiwan
12:00am
8-K
EX-10.2
ktbv8oi4pcdk8tzimb
7 Sep 10
BioDelivery Sciences Adds New Executive
12:00am
8-K
EX-10.1
5p08luaiyu
7 Sep 10
BioDelivery Sciences Adds New Executive
12:00am
8-K
EX-10.1
gl41xxpu k6avf
27 May 10
Commercial Partnership for BEMA Fentanyl in South Korea
12:00am
8-K
EX-10.1
amuj5 31ne
20 Apr 10
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.2
wnpv 4gdco2ih1jkg
31 Dec 09
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
zgl6ah5vch
31 Dec 09
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.3
stbut2rwb65loiobo8lt
31 Dec 09
Entry into a Material Definitive Agreement
12:00am